Table 1: Patient characteristics.
| Epithelial gap study | Vascular flow study | ||
| Demographic | CD (n = 16) | UC (n = 10) | UC (n = 9) |
| Age (mean ± SEM) | 12.76 ± 1.25 | 11.83 ± 0.54 | |
| Sex (m/f) | 7/9 | 3/7 | 3/6 |
| New onset | 8 | 0 | 0 |
| Follow-up | 8 | 10 | 9 |
| Treatments (%) | |||
| 5-aminosalicylic acid | 0 | 50 | 44 |
| Sulfasalazine | 9 | 10 | 11 |
| Prednisone | 0 | 40 | 33 |
| Azathioprine | 15 | 50 | 44 |
| Methotrexate | 16 | 10 | 11 |
| Infliximab | 15 | 30 | 23 |
IBD: Inflammatory Bowel Diseases; CD: Crohn Disease; UC: Ulcerative Colitis; f: female; m: male.